WallStreetZenWallStreetZen
Analyst Ranking
Top 34%
#1525 out of 4527 analysts
Average Return
+2.15%
Win Rate
36%8 out of 22
Risk vs Reward
Poor
Good

Justin Walsh's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Perspective Therapeutics IncCATX
+376.19%$0.25$1.20
2023-11-15 -
2024-03-27
Strong Buy
Harrow IncHROW
+261.36%$5.90$21.32
2022-05-20 -
2023-05-19
Strong Buy
Lantheus Holdings IncLNTH
+70.72%$55.54$94.82
2022-05-09 -
2023-05-08
Strong Buy
Compass Therapeutics IncCMPX
+48.76%$2.83$4.21
2022-01-19 -
2023-01-18
Strong Buy
Cytosorbents CorpCTSO
+30.19%$2.12$2.76
2022-05-04 -
2023-05-03
Strong Buy

Justin Walsh Analyst Color

Get additional color on Justin Walsh's coverage of popular stocks

Justin Walsh's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Lantheus Holdings IncLNTH
4Strong Buy$95.00+57.13%Maintains
3 months ago
Perspective Therapeutics IncCATX
1Strong Buy$1.40+16.67%Initiates Coverage On
4 months ago
Cytosorbents CorpCTSO
2Strong Buy$4.00+330.11%Reinstates
7 months ago
Prime Medicine IncPRME
1Strong Buy$20.00+195.86%Initiates Coverage On
7 months ago
Theratechnologies IncTHTX
1Strong Buy$12.00+721.92%Maintains
8 months ago
Vor Biopharma IncVOR
2Strong Buy$18.00+714.48%Initiates Coverage On
10 months ago
Viewray IncVRAYQ
2Hold$1.00+3,900.00%Downgrades
a year ago
Tff Pharmaceuticals IncTFFP
1Strong Buy$175.00N/AInitiates Coverage On
a year ago
Mainz Biomed NvMYNZ
1Strong Buy$11.00N/AInitiates Coverage On
a year ago
Plus Therapeutics IncPSTV
1Strong Buy$75.00N/AInitiates Coverage On
a year ago
Fusion Pharmaceuticals IncFUSN
1Strong Buy$10.00N/AInitiates Coverage On
2 years ago
Point Biopharma Global IncPNT
1Strong Buy$22.00N/AInitiates Coverage On
2 years ago
Harrow IncHROW
1Strong Buy$20.00N/AMaintains
2 years ago
Curis IncCRIS
2Strong Buy$200.00N/AMaintains
2 years ago
Compass Therapeutics IncCMPX
1Strong Buy$10.00N/AInitiates Coverage On
2 years ago
Portage Biotech IncPRTG
1Strong Buy$40.00N/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.